These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 7834618)

  • 1. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines.
    Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ
    Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB.
    Otterson GA; Kratzke RA; Coxon A; Kim YW; Kaye FJ
    Oncogene; 1994 Nov; 9(11):3375-8. PubMed ID: 7936665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein expression of the RB-related gene family and SV40 large T antigen in mesothelioma and lung cancer.
    Modi S; Kubo A; Oie H; Coxon AB; Rehmatulla A; Kaye FJ
    Oncogene; 2000 Sep; 19(40):4632-9. PubMed ID: 11030152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E; Moro D; Gazzeri S; Brambilla C
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The expression of P16 and Rb proteins in 106 cases of lung cancer].
    Qin J; Chen G; Wang X
    Zhonghua Jie He He Hu Xi Za Zhi; 2000 Oct; 23(10):588-90. PubMed ID: 11372380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
    Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
    Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of bcl-2 is associated with p16INK4-mediated apoptosis in non-small cell lung cancer cells.
    Kataoka M; Wiehle S; Spitz F; Schumacher G; Roth JA; Cristiano RJ
    Oncogene; 2000 Mar; 19(12):1589-95. PubMed ID: 10734319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p16 and lack of pRB in primary small cell lung cancer.
    Yuan J; Knorr J; Altmannsberger M; Goeckenjan G; Ahr A; Scharl A; Strebhardt K
    J Pathol; 1999 Nov; 189(3):358-62. PubMed ID: 10547597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of p16INK4A inactivation in non small-cell lung cancers.
    Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E
    Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rb and p16INK4a expression in resected non-small cell lung tumors.
    Kratzke RA; Greatens TM; Rubins JB; Maddaus MA; Niewoehner DE; Niehans GA; Geradts J
    Cancer Res; 1996 Aug; 56(15):3415-20. PubMed ID: 8758904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines.
    Sartor M; Steingrimsdottir H; Elamin F; Gäken J; Warnakulasuriya S; Partridge M; Thakker N; Johnson NW; Tavassoli M
    Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation of abnormal RB, p16ink4a, and p53 expression with 3p loss of heterozygosity, other genetic abnormalities, and clinical features in 103 primary non-small cell lung cancers.
    Geradts J; Fong KM; Zimmerman PV; Maynard R; Minna JD
    Clin Cancer Res; 1999 Apr; 5(4):791-800. PubMed ID: 10213214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines.
    Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M
    Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the retinoblastoma susceptibility gene in non-small-cell lung cancer. The Lung Cancer Study Group.
    Reissmann PT; Koga H; Takahashi R; Figlin RA; Holmes EC; Piantadosi S; Cordon-Cardo C; Slamon DJ
    Oncogene; 1993 Jul; 8(7):1913-9. PubMed ID: 8390038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution.
    Grimison B; Langan TA; Sclafani RA
    Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
    Kelley MJ; Nakagawa K; Steinberg SM; Mulshine JL; Kamb A; Johnson BE
    J Natl Cancer Inst; 1995 May; 87(10):756-61. PubMed ID: 7563154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.
    Xu HJ; Hu SX; Cagle PT; Moore GE; Benedict WF
    Cancer Res; 1991 May; 51(10):2735-9. PubMed ID: 1850661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.